Differentially regulated targets in the fast-acting antidepressant effect of (R)-ketamine: A systems biology approach
Pharmacology Biochemistry and Behavior · 2023
DOI: 10.1016/j.pbb.2023.173523 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Pharmacology Biochemistry and Behavior, 2023. Verfasst von Ellen Scotton und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Psychiatry, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil; Pharmacology Department and Graduate Program in B…. Hauptthemen laut MEDLINE: Ketamine, Major Depressive Disorder. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 60 Literaturangaben.
Abstract (Originalsprache)
Approximately two-thirds of patients with major depressive disorder (MDD) fail to respond to conventional antidepressants, suggesting that additional mechanisms are involved in the MDD pathophysiology. In this scenario, the glutamatergic system represents a promising therapeutic target for treatment-resistant depression. To our knowledge, this is the first study using semantic approach with systems biology to identify potential targets involved in the fast-acting antidepressant effects of ketamine and its enantiomers as well as identifying specific targets of (R)-ketamine. We performed a systematic review, followed by a semantic analysis and functional gene enrichment to identify the main biological processes involved in the therapeutic effects of these agents. Protein-protein interaction networks were constructed, and the genes exclusively regulated by (R)-ketamine were explored. We found that the regulation of α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid (AMPA) receptor and N-methyl-d-aspartate (NMDA) receptor subunits-Postsynaptic Protein 95 (PSD-95), Brain Derived Neurotrophic Factor (BDNF), and Tyrosine Receptor Kinase B (TrkB) are shared by the three-antidepressant agents, reinforcing the central role of the glutamatergic system and neurogenesis on its therapeutic effects. Differential regulation of Transforming Growth Factor Beta 1 (TGF-β1) receptors-Mitogen-Activated Protein Kinases (MAPK's), Receptor Activator of Nuclear Factor-Kappa Beta Ligand (RANKL), and Serotonin Transporter (SERT) seems to be particularly involved in (R)-ketamine antidepressant effects. Our data helps further studies investigating the relationship between these targets and the mechanisms of (R)-ketamine and searching for other therapeutic compounds that share the regulation of these specific biomolecules. Ultimately, this study could contribute to improve the fast management of depressive-like symptoms with less detrimental side effects than ketamine and (S)-ketamine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Molecular Psychiatry, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil; Pharmacology Department and Graduate Program in Biological Sciences: Pharmacology and Therapeutics, Institute of Health…
- Institute of Biotechnology, Universidade de Caxias do Sul (UCS), Caxias do Sul, RS, Brazil. Electronic address: plcasa@ucs.br.
- Institute of Biotechnology, Universidade de Caxias do Sul (UCS), Caxias do Sul, RS, Brazil. Electronic address: fpabreu1@ucs.br.
- Institute of Biotechnology, Universidade de Caxias do Sul (UCS), Caxias do Sul, RS, Brazil. Electronic address: sasilva6@ucs.br.
- Laboratory of Molecular Psychiatry, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil.
- Institute of Biotechnology, Universidade de Caxias do Sul (UCS), Caxias do Sul, RS, Brazil. Electronic address: mvrossetto@ucs.br.
Zitieren
APA
Scotton, E., Casa, P. L., de Abreu, F. P., de Avila E Silva, S., Wilges, R. L. B., Rossetto, M. V., Géa, L. P., Rosa, A. R., & Colombo, R. (2023). Differentially regulated targets in the fast-acting antidepressant effect of (R)-ketamine: A systems biology approach. Pharmacology Biochemistry and Behavior. https://doi.org/10.1016/j.pbb.2023.173523
Vancouver
Scotton E, Casa PL, de Abreu FP, de Avila E Silva S, Wilges RLB, Rossetto MV, et al. Differentially regulated targets in the fast-acting antidepressant effect of (R)-ketamine: A systems biology approach. Pharmacology Biochemistry and Behavior. 2023. doi:10.1016/j.pbb.2023.173523
BibTeX
@article{Scotton2023,
author = {Scotton, Ellen and Casa, Pedro Lenz and de Abreu, Fernanda Pessi and de Avila E Silva, Scheila and Wilges, Renata Luiza Boff and Rossetto, Marcos Vinicius and Géa, Luiza Paul and Rosa, Adriane R and Colombo, Rafael},
title = {Differentially regulated targets in the fast-acting antidepressant effect of (R)-ketamine: A systems biology approach},
journal = {Pharmacology Biochemistry and Behavior},
year = {2023},
doi = {10.1016/j.pbb.2023.173523}
}
EUVIMED